Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|January 17, 2002
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's diseaseB A in t' Veld, A Ruitenberg, A Hofman, et al.
The Pharmacogenomics Journal|December 22, 2011
Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapyM L Becker, L L F S Elens, L E Visser, et al.
Cancer Epidemiology|March 1, 2022
Appendectomy and the subsequent risk of cancer: A prospective population-based cohort study with long follow-upA L van den Boom, B D A Lavrijssen, J Fest, et al.
British Journal of Clinical Pharmacology|March 18, 2004
Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquineM M van Riemsdijk, M C J M Sturkenboom, J M Ditters, et al.
Gastroenterology|July 13, 2000
Acute pancreatitis attributed to the use of interferon alfa-2bI A Eland, M C Rasch, M J Sturkenboom, et al.
BMC Cancer|May 16, 2019
Prediction of response to pemetrexed in non-small-cell lung cancer with immunohistochemical phenotyping based on gene expression profilesS Visser, J Hou, K Bezemer, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Neuro-psychiatric effects of antimalarialsM M van Riemsdijk, M M van der Klauw, J A van Heest, et al.
Pain|September 2, 2008
Medical history and the onset of complex regional pain syndrome (CRPS)M de Mos, F J P M Huygen, J P Dieleman, et al.
Arthritis and Rheumatism|June 21, 2001
Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998P D van der Linden, E P van Puijenbroek, J Feenstra, et al.
European Journal of Cancer (Oxford, England : 1990)|September 28, 2019
Pemetrexed exposure predicts toxicity in advanced non-small-cell lung cancer: A prospective cohort studyS Visser, S L W Koolen, P de Bruijn, et al.
Pageof 19